STOCK TITAN

Procter & Gamble SEC Filings

PG NYSE

Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Procter & Gamble’s household brands—from Tide and Pampers to Gillette—generate billions across five global segments, and each quarter the company discloses exactly where that revenue comes from. If you have ever searched for “Procter & Gamble SEC filings explained simply,” this page is your direct route to the source data. Whether supply-chain costs shift or a new product line moves the needle, the underlying details live inside the filings we stream in real time.

Our platform automatically tags every form the moment it hits EDGAR. You can move from a single line item in the Procter & Gamble annual report 10-K simplified to the fresh numbers in the next Procter & Gamble quarterly earnings report 10-Q filing—all with AI-powered summaries that translate accounting jargon into plain language. Need to know when executives buy or sell? Receive alerts on Procter & Gamble Form 4 insider transactions real-time and review complete histories of Procter & Gamble executive stock transactions Form 4. Our AI further delivers “Procter & Gamble 8-K material events explained” so you grasp headline-moving announcements minutes after they post.

Investors use this hub to:

  • Compare segment margins without combing through hundreds of pages
  • Track currency impacts outlined in each 10-Q
  • Monitor Procter & Gamble insider trading Form 4 transactions before earnings dates
  • Review the Procter & Gamble proxy statement executive compensation for pay-for-performance alignment
  • Dive into Procter & Gamble earnings report filing analysis prepared by our expert engine

If you are understanding Procter & Gamble SEC documents with AI for the first time or you are a seasoned analyst refining a model, our real-time updates, concise explanations, and complete coverage of every filing type keep you focused on decisions, not document hunting.

Filing
Rhea-AI Summary

Filing excerpt opposes shareholder proposals on plastics and ESG The document is a proxy-related submission addressing Procter & Gamble's consideration of plastics, recycling and circular-economy proposals. It argues that proponents are agenda-driven activists and cites multiple reports and sources to challenge claims that plastics production is the primary cause of ocean pollution or greenhouse-gas impacts. The filing contends that waste management and disposal, not production, drive plastic leakage into oceans and highlights studies it says show plastics can have lower life-cycle GHG emissions than alternatives. It urges P&G to rely on "scientifically rigorous and economically sensible" analysis rather than adopt activist-driven targets or packaging mandates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported transactions on 09/15/2025. The filing shows a disposition of 13,106.0044 shares of common stock and an acquisition by exercise of a stock option (right to buy) for 11,420 shares with a stated exercise price of $156.83. The filing also discloses 5,112.6018 shares held indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 09/17/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
insider
-
Rhea-AI Summary

Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported transactions dated 09/15/2025. The filing shows a disposition of 28,036.3817 shares of Common Stock and the acquisition of a stock option award for 26,231 underlying shares with an exercise price of $156.83. The option award is listed as acquired on 09/15/2025, becomes exercisable on 09/15/2028 and expires 09/14/2035. The report lists indirect beneficial ownership stakes of 3,301.9815 shares held by a retirement plan trustee, 19,757 shares held by the Sankhya S Jejurikar Revocable Trust, and 17,849 shares held by the Shailesh Jejurikar Trust. The form is signed by an attorney-in-fact on 09/17/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
insider
Rhea-AI Summary

Reporting person: Aguilar Moses Victor Javier, Chief Research, Development & Innovation Officer at Procter & Gamble Co (PG). Transactions on 09/15/2025: the Form 4 discloses a disposition of 40,841.1704 shares of P&G common stock and continuing indirect holdings of 6,750.7456 shares held by a Retirement Plan Trustee and 428.6033 shares held by an International Stock Ownership Plan (Mexico) Trustee. The filing also reports an acquisition (transaction code A) of 6,852 stock options tied to 6,852 underlying common shares with a stated conversion/exercise price of $156.83 and a listed price of $0; the options show exercisability beginning 09/15/2028 and expiration 09/14/2035. The form is signed by an attorney-in-fact on behalf of Mr. Aguilar on 09/17/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
insider
-
Filing
Rhea-AI Summary

Procter & Gamble faces rising risks from its use of flexible plastic packaging. The filing highlights growing financial exposure if governments force producers to pay full waste-management costs, citing an estimated collective industry risk of $100 billion. Seven U.S. states have passed extended producer responsibility (EPR) laws that charge higher fees for hard-to-recycle materials. The company reported flexible packaging rising from 12.7% in 2021 to 19.6% in 2022, with unrecyclable multi-material flexibles at 14% and difficult-to-recycle mono-material flexibles at 5% (mono-material films rose from 0% to 5.2%). These gaps are presented as creating regulatory, financial, and reputational risk and as undermining P&G’s stated packaging goals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Patricia A. Woertz, a director of Procter & Gamble Co (PG), received 189 Restricted Stock Units (RSUs) on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The grant includes dividend equivalents credited as additional RSUs, and after the award Ms. Woertz beneficially owns 51,517.5268 shares. The RSUs were reported on Form 4 and documented by an attorney-in-fact signature dated 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider
Rhea-AI Summary

Christopher J. Kempczinski, a director of Procter & Gamble Co (PG), was awarded 197 Restricted Stock Units (RSUs) on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a price of $0 and the reported total beneficial ownership after the award is 9,166.4401 common shares, which includes dividend equivalents credited as additional RSUs. The filing reports the grant as a non‑derivative equity award and identifies the award as restricted stock units and dividend equivalents; no options, sales, or cash transactions are disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider
-
Rhea-AI Summary

Craig Arnold, a director of Procter & Gamble Co. (PG), was granted 189 restricted stock units (RSUs) on 09/09/2025. The award is under The Procter & Gamble 2019 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional RSUs. The filing reports 703.4862 shares (or RSU-equivalent) beneficially owned by the reporting person after the transaction. The Form 4 was signed by an attorney-in-fact on 09/10/2025 and discloses this non-derivative equity award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider
-
Rhea-AI Summary

Robert J. Portman, a director of Procter & Gamble Co. (PG), was granted 48 Restricted Stock Units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were recorded at a price of $0 and the reporting shows 3,419.5944 shares beneficially owned after the grant, a total that the filing states includes dividend equivalents credited as RSUs. The Form 4 was filed as a single-person filing and signed by an attorney-in-fact on 09/10/2025. The document contains only the listed grant details and explanatory footnotes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider
Rhea-AI Summary

Ashley McEvoy, a director of Procter & Gamble Co (PG), was awarded 189 shares of Common Stock on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The grant carries a $0 per-share transaction price and the total post-transaction beneficial ownership is reported as 3,843.0241 shares, which the filer says includes dividend equivalents issued as Restricted Stock Units. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing discloses a routine equity award to a director as part of compensation; no sale or cash purchase occurred.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider

FAQ

What is the current stock price of Procter & Gamble (PG)?

The current stock price of Procter & Gamble (PG) is $152.42 as of September 24, 2025.

What is the market cap of Procter & Gamble (PG)?

The market cap of Procter & Gamble (PG) is approximately 356.9B.
Procter & Gamble

NYSE:PG

PG Rankings

PG Stock Data

356.92B
2.34B
0.07%
70.21%
0.74%
Household & Personal Products
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Link
United States
CINCINNATI